Purebase (PUBC) director reprices options to $0.06, term to 2030

Purebase Corp (PUBC) filed a Form 4 showing a director’s option repricing and extension effective 02/06/2025.

Rhea-AI Filing Summary

Purebase Corp (PUBC) filed a Form 4 showing a director’s option repricing and extension effective 02/06/2025. Previously granted stock options with exercise prices of $0.15, $0.24, and $0.36 were canceled and replaced with new options at $0.06 per share, now expiring on 02/06/2030.

The replacement covered multiple tranches, including 200,000 and 242,424-share options. This is a non-cash compensation adjustment that lowers strike prices and extends terms, as noted in the filing’s explanation of responses.

Insights

Equity compensation analyst

Administrative option repricing; neutral impact.

Purebase disclosed a director option exchange: higher-strike grants at $0.15, $0.24, and $0.36 were canceled and replaced at $0.06, with the new options expiring on 02/06/2030. This is a non-cash modification of existing awards.

Repricings reduce the exercise hurdle and extend potential value duration, but actual dilution depends on future exercises. The filing lists specific tranches, including 200,000 and 242,424 options, without aggregating totals.

There is no cash component to the company in this disclosure. Subsequent filings may provide broader board-level compensation context or additional award details, if any.

Insider Trade Summary

8 transactions reported

Mixed 8 txns

Insider Kurtis Kimberly Erin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock option (right to buy)	200,000	$0.06	$12K
Grant/Award	Stock option (right to buy)	200,000	$0.06	$12K
Grant/Award	Stock option (right to buy)	242,424	$0.06	$15K
Grant/Award	Stock option (right to buy)	200,000	$0.06	$12K
Disposition	Stock option (right to buy)	200,000	$0.15	$30K
Disposition	Stock option (right to buy)	200,000	$0.24	$48K
Disposition	Stock option (right to buy)	242,424	$0.24	$58K
Disposition	Stock option (right to buy)	200,000	$0.36	$72K

Holdings After Transaction: Stock option (right to buy) — 1,684,848 contracts (Direct)

Footnotes (1)

1. F1. Cancellation of option in connection with grant of replacement option with the repricing of the exercise price to $0.06 per share and the extension of the term of the option to 2/6/2030.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Purebase (PUBC) disclose in this Form 4?

A director canceled prior stock options and received replacement options repriced to $0.06 per share, expiring on 02/06/2030.

What were the original option exercise prices before the repricing at PUBC?

The canceled options had exercise prices of $0.15, $0.24, and $0.36 per share.

When did the earliest reported transaction occur for PUBC?

The earliest transaction date reported is 02/06/2025.

What are the sizes of some replacement option tranches at PUBC?

The filing lists tranches including 200,000 options and 242,424 options.

Is there any cash impact to Purebase from this Form 4 event?

No. The filing reflects a non-cash compensation change via option cancellation and replacement.

What is the new expiration date for PUBC’s replacement options?

The replacement options expire on 02/06/2030.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/23/2025 - 04:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kurtis Kimberly Erin

(Last) (First) (Middle)

805 ADAIR AVENUE NE

(Street)

ATLANTA GA 30306

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Purebase Corp [ PUBC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	$0.06	02/06/2025		A		200,000		02/06/2025	02/06/2030	Common stock	200,000	$0.06	200,000	D
Stock option (right to buy)	$0.06	02/06/2025		A		200,000		02/06/2025	02/06/2030	Common stock	200,000	$0.06	200,000	D
Stock option (right to buy)	$0.06	02/06/2025		A		242,424		02/06/2025	02/06/2030	Common stock	242,424	$0.06	242,424	D
Stock option (right to buy)	$0.06	02/06/2025		A		200,000		02/06/2025	02/06/2030	Common stock	200,000	$0.06	200,000	D
Stock option (right to buy)	$0.15	08/10/2023		D(1)			200,000	08/10/2023	02/06/2025	Common stock	200,000	$0.15	200,000	D
Stock option (right to buy)	$0.24	08/26/2022		D(1)			200,000	08/26/2022	02/06/2025	Common stock	200,000	$0.24	200,000	D
Stock option (right to buy)	$0.24	08/26/2022		D(1)			242,424	08/26/2022	02/06/2025	Common stock	242,424	$0.24	242,424	D
Stock option (right to buy)	$0.36	08/13/2021		D(1)			200,000	08/13/2021	02/06/2025	Common stock	200,000	$0.36	200,000	D

Explanation of Responses:

1. Cancellation of option in connection with grant of replacement option with the repricing of the exercise price to $0.06 per share and the extension of the term of the option to 2/6/2030.

	/s/ Kimberly E Kurtis	10/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.